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INTRODUCTION 
The pineal is a small gland (1.0 mg. in rats) 
located between the cerebral hemispheres. It contains a 
variety of active indoleamines and monoamines, the major 
one being melatonin, a seratonin derivative. The concen-
tration of biosynthetic enzymes within the pineal, and the 
secretion of melatonin from the pineal exhibits a circadian 
rhythm as seen in Fig. #1 (Brooks, et. al., 197S). 
Melatonin is synthesized ·from the amino acid 
' tryptophan through a series of enzyme and co-factor 
specific reactions (Fig. #2). Tryptophan is first hydrox-
ylated at the five position through the action of tryptophan 
hydroxylase. S-OH tryptophan is rapidly decarboxylated by 
dihydroxyphenylalanine decarboxylase to S-OH tryptamine 
(serotonin). This compound is an important neurotrans-
mitter found in large concentrations in specific areas of 
the central nervous system, including the pineal. N-acetylase 
converts serotonin to N-acetyl serotonin. N-acetyl sero-
tonin has a much greater affinity for the enzyme hydroxy 
indole o-methyl transferase (HIOMT) than does serotonin. 
HIOMT is found almost exclusively in the cytoplasm of the 
pineal parenchymal cells, and transfers an active methyl 
grm..;p from s-adenosyl methionine to the S-position of this 
melatonin presursor. One major physiological effect of the 
action of HIOMT is to convert indoleamines such as serotonin 
which cannot cross the blood barrier, into compounds such 
as melatonin which easily gain access to the brain. 
As shown in Fig. #2 each enzymatic step for the 
formation of melatonin from typtophan requires a different 
specific co-factor. Tryptophan hydroxylase requires NADPH 
and tetrahydrobiopterin. Pyridexyl phosphate (vitamin B6 ) 
is necessary as a co-factor for the action of dihydroxy-
phenylalanine decarboxylase. Acetyl groups for the N-acetyl-
ation of serotonin come from acetyl CoA, while S-adenosyl 
methionine donates the methyl group for the a-methylation 
of N-acetyl serotonin. Formation of melatonin from tryp-
tophan in pineal organ cultures, without the addition of 
co-factors, indicates that this organ contains, or is 
capable of synthesizing, sufficient amounts of these com-
pounds for the production of melatonin (Axelrod, 1974). 
Light has a major regulatory effect on pineal 
indoleamine biosynthesis and secretion. A circadian rhythm 
(Fig. #1) is exhibited by the pineal secretions. Connection 
between the eye and the pineal follows a direct sympathetic 
pathway (Axelrod, 1974). Maintenance of melatonin biosyn-
thetic activity requires continuous occupation of the 
adrenergic receptors by the sympathetic neurotransmitter 
norepinephrine. Light reduces the release of norepinephrine 
from the sympathetic fibers and a rapid fall in melatonin 
production and secretion ensues. As can be seen from Fig. #1 
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the concentration of melatonin secreted by the pineal 
reaches its lowest level about three hours after the onset 
of daylight. One hour after darkness there is a 30 to 
50 fold increase in pineal N-acetylast activity (Binkley, 
1976). This increase in pineal N-acetylase activity after 
the onset of darkness is responsible for a 10 times greater 
concentration of melatonin at night above daytime values 
(Romero, et. al., 1975b). Melatonin concentration reaches 
a peak approximately three hours after the onset of dark-
ness (Axelrod, 1974). 
S adrenergic blocking agents inhibit indoleamine 
biosynthesis and secretion, while aadrenergic blocking 
agents effect no change (Klein & Weller, 1973). Sadrenergic 
stimulation results in the activition of adenyl cyclase to 
produce 3'4' cyclic adenosine menophosphate. This suggests 
that melatonin biosynthesis and secretion are another of 
the more than 30 hormonal reactions known to be mediated by 
cyclic AMP (Romero, et, al., 1975a). 
A number of different experimental techniques have 
shown a relationship between melatonin, glucose tolerance, 
and insulin release. In vivo studies have indicated an 
inhibition of insulin release by many monoamines such as 
epinephrine (Kriss, 1966), and norepinephrine (Porte & 
Williams, 1966), L-dopa and dopamine also increase blood 
glucose levels, suggesting a reduction in the release of 
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insulin (Lundquist, 1972). Serotonin has also been shown 
to inhibit glucose mediated insulin release (Feldman & 
Lebowitz, 1972; Feldman, et. al., 1972). Melatonin has 
been implicated in decreasing the basal insulin secretion 
rate from cultured rat islet cells (Bailey, 1974; Csaba 
& Barath, 1971; Milcu, et. al., 1971; Csaba & Nagy, 1971). 
In vivo studies on anesthetized cannulated rats have shown 
a slight decrease in glucose tolerance due to intravenous 
melatonin administration (Bailey, 1974). 
A monoaminergic mechanism has been proposed to 
explain this inhibition of insulin release (Lundquist, 1972), 
but the exact details of the mechanism are not presently 
understood. Treatment with monoamine oxidase (MAO), which 
degradesmonoamines, decreases the active concentration of 
monoamines. Treatment with MAO inhibitors produces a 
decrease in the degratory activity of the MAO system, and 
therefore allows monoamines to effectively increase in 
concentration. This increase in monoamine activity produces 
a decrease in insulin production and/or release, thereby 
producing an increase, or perhaps more accurately, a lack 
of decrease in plasma glucose (Lundquist, 1972). 
Studies on rat islet preparations have shown mela-
tonin inhibits MAO activity and thereby reduces glucose 
mediated insulin release (Ellis, 1976), The objective of 
this work is to investigate the effects of melatonin on 
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insulin release, and on glucose mediated insulin release 
in the intact and in the pinealectomized rat. 
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METHODS AND MATERIALS 
A total of 75 rats were obtained from random bred 
long Evans stock. Twenty-five were used as controls, and 
pinealectomies were performed on the remaining 50 animals 
using a modification of two techniques (Hoffman & Reiter, 
1965; Bliss & Bates, 1973). The animals were anesthetized 
with ether and the skin and fascia overlying the skull were 
opened by longitudinal incision. A 0.5 em. wide disc was 
cut in the skull using a dental drill with a thin-walled, 
tube-shaped bit. This bone disc was removed from the skull 
with a pair of forceps, leaving an opening in the skull 
anterior to the lamboidal suture and lateral to the saggital 
suture. Microforceps, opened 2 to 3 mm., were then inserted 
into the cranium at an angle of approximately 45° downward 
and 45° lateral to the saggital suture, rupturing the 
saggital sinus just anterior to the transverse sinus. The 
forceps were then moved approximately 3 mm. medioposteriorly, 
closed around the unexposed pineal, and retracted through 
the entry path. Although the pineal was not visible through 
the skull opening with this technique, it has the advantage 
that bleeding was kept to a minimum. The bone disc was 
replaced and the skin incision closed using metal sutures. 
Using this technique the fatality rate was 4%. 
The pinealectomized rats were divided into two test 
groups. The animals in one group (P+M) were injected with 
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melatonin (Sigma) intraperitoneally at a dose of 500 mg./kg. 
body wt., at 2200 hours daily for three days prior to any 
test. The pinealectomized animals making up the other 
group (P) were not injected with melatonin. A third group 
of animals upon which no operation had been performed (C) 
served as controls. Two test treatments were run on each 
test group: (1) glucose tolerance test; (2) saline control 
test (Table 1). For the glucose tolerance test a 20% 
glucose solution was administered intraperitoneally at a 
dose of 300 mg./kg. body wt. Locke-Ringers solution was 
injected (1.5 ml./kg. body wt.) for the saline control tests. 
The effects of pineal secretions within each rat were 
standardized by starting all tests within one hour of 1000 
hours. Blood samples were collected in heparinized capillary 
tubes using the tail-cut method 30 minutes, 15 minutes, and 
immediately prior to the injection of the glucose or saline 
solution. All samples were centrifuged in a microhematocrit 
(International Equipment Co.) for 5 minutes, the packed red 
cells discarded, and the plasma tested for glucose con-
centration. Plasma glucose levels were estimated using 
the glucose oxidase method (Sigma, 1974). Plasma glucose 
levels were converted to percent change from each animals 
lowest pre-injection level. By using this method differences 
that occurred in initial plasma glucose were standardized. 
Some pinealectomized animals were used for more than 
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one test in the (P) or (P+M) groups. If a second test was 
performed on an animalt at least two weeks were allowed 
after the first test was completed. In these cases the 
animal was used in the (P+M) group last so the injection 
of melatonin would not interfere with later tests. No 
animal was used in the same group for the same test more 
than once. 
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RESULTS 
Following the injection of the glucose solution 
all animals exhibited a rapid increase in plasma glucose, 
reaching a peak approximately 15 minutes after the injection 
(Fig. #3). The magnitude of the increase in the percent 
change in "mean plasma glucose" (MPG) in the (P+M) group 
(65%) was greater than the increase in either the (P) 
group (38%) or the (C) group (33%). The percent change in 
MPG of all three groups then decreased, stabilizing about 
90 minutes post-injection. The percent change in MPG of 
the (P+M) group stabilized approximately 20% higher than 
the other two groups. MPG concentrations for the (P) and 
(C) animals stabilized about 5% below their pre-injection 
levels, while that of the melatonin injected animals, (P+M), 
stabilized around 15% above their pre-injection levels. 
An increase in MPG followed the injection of saline 
in all three groups. The increase of the (P+M) group was 
approximately 30%, while both the (P) and (C) groups MPG 
increased less than 10%. The MPG values of all three 
groups then decreased and eventually stabilized about 90 
minutes following the saline injection. The MPG of the (P) 
and (C) groups stabilized about 10-12% below their pre-
injection level while that of the (P+M) group leveled off 
about 15% above their pre-injection level, which is 25% 
higher than the final value of the other groups. 
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Although injection of both glucose and saline caused 
an increase in the MPG of all groups (Fig. #3), the extent 
of this increase varied considerably between groups during 
the glucose tolerance and saline control tests. Injection 
of glucose injection caused a greater increase in MPG in 
all test groups than did saline injection. After the 
administration of glucose the MPG of the (P+M) group 
increased approximately 65% over the lowest pre-injection 
level. Following the saline injection the MPG of the (P+M) 
group increased 32%. The (P) group increased its MPG 39% 
after the glucose injection, and only 8% following the 
saline injection. The MPG of the (C) group increased 33% 
following the glucose injection and 5% after the saline 
injection. Each group shows an increase in MPG of between 
30% to 35% higher following the glucose injection '-vhen 
compared to the increase in MPG following the saline 
injection. 
F-tests showed no signfficant difference between 
sexes during either the glucose or saline tests, so the 
sexes '"ere treated together (Table fftl). The F-test did 
show a significant difference within the three groups, (P+M); 
(P); (C), during the glucose test and during the saline 
test (Table #1). Group variations within each test were 
determined by the use of T-tests. As can be seen from 
Table #2 the (P) and (C) groups showed no significant 
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variation between each other in either the glucose or 
saline test. The (P+M) group varied significantly from 
both the (P) and (C) groups in both the glucose and the 
saline tests. 
Broken capillary tubes or insufficient volumes 
of plasma samples caused a few missing values. These miss-
ing values were estimated by the use of regressions. 
Correlation co-efficients were run to determine which type 
of regression more closely represented each groups test 
data. Linear regressions showed the closest correlation 
and were used to estimate the missing values for both the 
glucose and saline treated animals. 
Autopsies were performed on all animals to verify 
removal of the pineal. Data from any animal which still 
had any portion of the pineal remaining were discarded. 
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DISCUSSION 
The (P+M) group exhibits a reduced glucose toler-
ance relative to the (P) group. (Fig. #3) The only experi-
mental difference between these two groups was the nocturnal 
injection of melatonin given the (P+M) group. The difference 
in change in plasma glucose suggests that melatonin is 
responsible for the observed glucose intolerance, and 
therefore, inhibits insulin biosynthesis and/or release. 
If melatonin did not influence glucose metabolism the per-
cent change in plasma glucose of the two groups would have 
been similar. 
The relationship between the (P+M) group and the (C) 
group is much more complex. Both groups have melatonin 
introduced during the night hours. The (C) group has mela-
tonin secreted from the pineal in response to the onset of 
darkness. The (P+M) group received an injection of melatonin 
at 2200 hours, approximately when the (C) group experiences 
its largest secretion rate of melatonin. However, these 
groups vary in glucose tolerance when tested at 1000 hours. 
A significantly greater amount of melatonin may be present 
in the systems of the (P+M) group, due to the injection of 
melatonin, to effect the noted glucose intolerance at 1000 
hours. The (C) group may have metabolized physiologically 
active levels of melatonin from their blood while the (P+M) 
group may still have active concentrations in their systems 
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from the injection. 
At the tolerance test starting time the melatonin 
concentration in the (C) animals is at the low point of 
their circadian cycle. The (P) group does not have 
physiologically active levels of melatonin due to the 
removal of the pineal gland. These two groups exhibited 
no significant variation in glucose tolerance during the 
test. In the (C) group physiologically active amounts of 
the nocturnally secreted melatonin must be metabolized by 
the liver so that the concentration of melatonin present 
at 1000 hours is not significantly greater than the mela-
tonin levels of the (P) group. In both the (P) and (e) 
groups melatonin levels are not high enough to significantly 
affect glucose metabolism at 1000 hours. 
The lack of difference between the (P) group and 
the (C) group and the significant difference between both 
and the (P+M) group suggests that while the normal nocturnal 
secretions of melatonin are metabolized by the liver to 
below physiologically active concentrations the injected 
dose of melatonin is not reduced to the same low levels and 
a reduction in glucose tolerance ensues in the injected rats. 
An increase in plasma glucose is observed in all 
three groups following the injection of the saline solution 
(Fig. #4). This increase in mean plasma glucose, 32% for 
the (P+M) group, 8% for the (P) group, and 5% for the (C) 
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group is not as large as the increase seen in the glucose 
tolerance test and is most likely due to the stress of the 
experimental procedure. All plasma glucose curves reach 
a peak about 15 minutes after the saline injection. As in 
the glucose tolerance test a large variation occurs in the 
magnitude of this increase between the melatonin injected 
group (P+M) and the other two groups, (P) and (C). While 
the increase in MPG of the (P) and (C) groups are not 
significantly different, (T<{0,01}), both vary significantly 
from the (P+M) group (T>{0.01}). The normal release of 
insulin in response to the increase in plasma glucose levels 
elicited by the stressful situation allowed the MPG of the 
(C) group to increase only 5%. The increase in MPG of the 
(P) group, 8%, did no~ vary significantly from this. The 
amount of melatonin injected into the (P+M) animals resulted 
in apparently greater than normal levels of melatonin, as 
MPG of the (P+M) group increased 35%. This increase in 
MPG suggests an inhibition of the islets response capacity, 
mediated by melatonin. After 90 minutes the MPG of the (P) 
and (C) groups decreased and stabilized approximately 10% 
below the lowest pre-injection level, while that of the 
(P+N) group stabilized at 15% above the lowest pre-injection 
level. This 25% difference in stabilization levels suggest 
a suppression of insulin production and/or release in the 
melatonin injected animals. 
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The most probably explanation for the difference in 
MPG of the (P+M) group from both the (P) and (C) groups 
during the glucose tolerance and saline control tests is 
alterations in the monoamine system caused by the melatonin 
injection. Melatonin is degraded by the MAO system. By 
increasing the concentration of melatonin the effectiveness 
of the MAO system in degrading other monoamines is reduced, 
A decrease in the degratory activity of the MAO system would 
increase the activity of monoamines. The relative increase 
in monoamine activity could cause the observed decrease in 
glucose tolerance. This mechanism appears to be the most 
plausible reason for the inability of the melatonin injected 
pinealectomized animals to reduce their mean blood glucose 
concentrations to normal levels during the two hours follow-
ing the test injection. 
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SUMMARY 
The pineal is an active endocrine gland converting 
a neural input into a hormonal output. Secretion of 
monoamines from the pineal is regulated by light and exhibits 
a circadian rhythm. Melatonin, the major pineal secretion, 
has been implicated in altering insuline production and/or 
release, and in reducing glucose tolerance. 
Intact animals exhibit a specific glucose tolerance 
at 1000 hours. The glucose tolerance of pinealectomized 
animals at the same time is not significantly different. 
The normal production and secretion of melatonin does not 
significantly alter glucose metabolism at 1000 hours, but 
the injection of an apparently supraphysiological dose of 
melatonin at 2200 hours for each of three days prior to 
the tolerance test significantly reduced glucose tolerance. 
This study has shown a relationship between mela-
tonin injection and reduced glucose tolerance in the labor-
atory rat, Although the exact mechanism by which melatonin 
acts on glucose tolerance has not been ascertained, a 
reduction in insulin production and/or release is the probable 
cause of the decreased glucose tolerance. A monoaminergic 
mechanism involving melatonin seems the most likely means 
by which this action is effected. 
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Source df 
Glucose 
Tolerance Test Groups 
Saline 
Control Test 
Sexes 
Groups 
Sexes 
2 
1 
2 
1 
ss 
2.293 
.107 
2. 170 
. 027 
ms F 
1.146 8.276 F2 , 27 =5.5 
. 107 . 774 F 1 , 27 =7. 7 
1.085 13.478 F2 , 27=5.5 
.027 .339 F1 , 27=7. 7 
Table 1. Group variations between the three test groups, 
(P); (C); (P+M), within each test. 
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Glucose DF T-Value 
c X p 21 0.887 T 0.01 = 2.83 
P+MxC 22 3.678 T 0.01 = 2.82 
P+MxP 20 6.950 T 0.01 = 2.85 
Saline 
c X p 20 1.800 T 0.01 = 2.85 
P+MxC 21 14.500 T 0.01 = 2.83 
P+MxP 20 31.800 T 0.01 = 2.85 
Table 2. Variation between paired test groups within 
each test using students T-test. 
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